Katherine Chiu
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (30)
Precision medicine holds great promise for improving cancer outcomes. Yet, there are large inequities in the demographics of patients from whom genomic data and models, including patient-derived xenografts (PDX), are developed and for whom treatments are optimized. In this study, we developed a genetic ancestry pipeline for the Cancer Genomics Cloud, which we used to assess the diversity of models currently available in the National Cancer Institute–supported PDX Development and Trial Centers Research Network (PDXNet). We showed that there is an under-representation of models derived from patients of non-European ancestry, consistent with other cancer model resources. We discussed these findings in the context of disparities in cancer incidence and outcomes among demographic groups in the US, as well as power analyses for biomarker discovery, to highlight the immediate need for developing models from minority populations to address cancer health equity in precision medicine. Our analyses identified key priority disparity-associated cancer types for which new models should be developed. Significance: Understanding whether and how tumor genetic factors drive differences in outcomes among U.S. minority groups is critical to addressing cancer health disparities. Our findings suggest that many additional models will be necessary to understand the genome-driven sources of these disparities.
Year:
2024
Ancestral estimates 1000Genomes individuals (n=929) not used in reference panel generation. Estimates calculated from 1000Genomes K=10 admixture data, SNPWeights Panel, and the differences between these estimates for each individual.
Year:
2024
Figure S1 shows the Clustering of 1,990 non-admixed reference samples and 2,387 admixed samples(brown) individuals based on the first three principal components. Colors represent the continental ances
Year:
2024
1000Genomes K=10 Admixture Estimates downloaded from ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/20130502/supporting/admixture_files/ALL.wgs.phase3_shapeit2_filtered.20141217.maf0.05.10.Q. Super-population designations were added to the partitions by sorting each partition and determining the corresponding designation for each partition.
Year:
2024
PDXnet metadata for samples for which genetic ancestry was estimated and samples were assigned into African (AFR), European (EUR), East Asian (EAS), American (AMR), and South Asian (SAS) continental ancestry.
Year:
2024
PDXnet metadata for samples for which genetic ancestry was estimated and samples were assigned into African (AFR), European (EUR), East Asian (EAS), American (AMR), and South Asian (SAS) continental ancestry.
Year:
2024
1000Genomes K=10 Admixture Estimates downloaded from ftp://ftp.1000genomes.ebi.ac.uk/vol1/ftp/release/20130502/supporting/admixture_files/ALL.wgs.phase3_shapeit2_filtered.20141217.maf0.05.10.Q. Super-population designations were added to the partitions by sorting each partition and determining the corresponding designation for each partition.
Year:
2024
Ancestral estimates 1000Genomes individuals (n=929) not used in reference panel generation. Estimates calculated from 1000Genomes K=10 admixture data, SNPWeights Panel, and the differences between these estimates for each individual.
Year:
2024
Figure S2 shows Diversity of genetic ancestry estimates from PDXNet breast cancer models. A: Inferred genetic ancestry for 115 breast cancer models in PDXnet. B: Top two categories for 26 "MIXED" samp
Year:
2024
Figure S2 shows Diversity of genetic ancestry estimates from PDXNet breast cancer models. A: Inferred genetic ancestry for 115 breast cancer models in PDXnet. B: Top two categories for 26 "MIXED" samp
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Year:
2024
Collaborators (2)
Jeffrey Chuang
Jackson Laboratory
Luis G Carvajal‐Carmona
Professor
University of California, Davis
Make your next move.
Prepare your application
Review drafts before you send them.